EPISODE · Jun 6, 2025 · 1H 22M
First Jury Trial Involving Covid Death Underway
from The Tom Roten Show · host Uncommon Media Group
Scott Schara, Grace's Dad, gives the background on a landmark trial that began earlier this week (June 2, 2025). The trial of Schara v. Ascension Health, et al addresses the alleged wrongful death of Grace Schara, a 19-year-old with Down syndrome, and the trial results could have broader implications for accountability in U.S. healthcare. This is the first wrongful death jury trial in the country for a death listed as COVID-19 on the death certificate. The unique claims in this case include medical battery and a declaratory judgment ruling regarding the DNR order and the order for three contraindicated medications – Precedex, Lorazepam, and Morphine. My interview with Scott was originally recorded Dec. 4, 2023, but all the information is still relevant.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-tom-roten-show--5987430/support.
What this episode covers
Scott Schara, Grace's Dad, gives the background on a landmark trial that began earlier this week (June 2, 2025). The trial of Schara v. Ascension Health, et al addresses the alleged wrongful death of Grace Schara, a 19-year-old with Down syndrome, and the trial results could have broader implications for accountability in U.S. healthcare. This is the first wrongful death jury trial in the country for a death listed as COVID-19 on the death certificate. The unique claims in this case include medical battery and a declaratory judgment ruling regarding the DNR order and the order for three contraindicated medications – Precedex, Lorazepam, and Morphine. My interview with Scott was originally recorded Dec. 4, 2023, but all the information is still relevant.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-tom-roten-show--5987430/support.
NOW PLAYING
First Jury Trial Involving Covid Death Underway
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m